Georg Evers
Impact in
- Neurology top 10%
- Long-Term Effects of COVID-19
-
- Cancer Immunotherapy and Biomarkers
- Lung Cancer Research Studies
Papers in
-
- Lung Cancer Diagnosis and Treatment 5
- Lung Cancer Treatments and Mutations 4
- Tracheal and airway disorders 4
-
- Acute Myeloid Leukemia Research 4
- Hematopoietic Stem Cell Transplantation 4
- Co-authors
- Arik Bernard Schulze (22 shared papers)Michael Möhr (27 shared papers)Wolfgang E. Berdel (14 shared papers)Christoph Schliemann (10 shared papers)Dennis Görlich (11 shared papers)Georg Lenz (14 shared papers)Annalen Bleckmann (16 shared papers)Ludger Hillejan (4 shared papers)
- Journals
- Cancers (6 papers)PLoS ONE (2 papers)Canadian Respiratory Journal (2 papers)Annals of Hematology (2 papers)Therapeutic Advances in Medical Oncology (2 papers)
- Partner nations
- GermanySwitzerlandUnited States
In The Last Decade
Georg Evers
45 papers receiving 659 citations
Peers
Comparison fields: 5 of 58
- Neurology 91
- Oncology 115
- Radiology, Nuclear Medicine and Imaging 104
- Hematology 59
- Pulmonary and Respiratory Medicine 129
Countries citing papers authored by Georg Evers
This map shows the geographic impact of Georg Evers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Georg Evers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Georg Evers more than expected).
Fields of papers citing papers by Georg Evers
This network shows the impact of papers produced by Georg Evers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Georg Evers. The network helps show where Georg Evers may publish in the future.
Co-authors
The 25 scholars most cited alongside Georg Evers, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 51 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 72 | |
| 2 | 2017 | 63 | |
| 3 | 2019 | 63 | |
| 4 | 2020 | 45 | |
| 5 | 2021 | 38 | |
| 6 | 2016 | 32 | |
| 7 | 2023 | 31 | |
| 8 | 2015 | 24 | |
| 9 | 2019 | 23 | |
| 10 | 2024 | 19 | |
| 11 | 2019 | 18 | |
| 12 | 2020 | 18 | |
| 13 | 2022 | 18 | |
| 14 | 2020 | 15 | |
| 15 | 2023 | 14 | |
| 16 | 2013 | 13 | |
| 17 | 2014 | 13 | |
| 18 | 2022 | 11 | |
| 19 | 2008 | 10 | |
| 20 | 2017 | 9 |
About Georg Evers
Georg Evers is a scholar working on Pulmonary and Respiratory Medicine, Hematology, Oncology, Neurology and Radiology, Nuclear Medicine and Imaging, having authored 51 papers that have together received 671 indexed citations. Recurring topics across this work include Lung Cancer Research Studies (6 papers), Lung Cancer Diagnosis and Treatment (5 papers), Lung Cancer Treatments and Mutations (4 papers), Cancer Immunotherapy and Biomarkers (4 papers), Acute Myeloid Leukemia Research (4 papers), Tracheal and airway disorders (4 papers), Long-Term Effects of COVID-19 (4 papers) and Hematopoietic Stem Cell Transplantation (4 papers). The work is most often cited by research in Neurology (91 citations), Oncology (115 citations), Radiology, Nuclear Medicine and Imaging (104 citations), Hematology (59 citations) and Pulmonary and Respiratory Medicine (129 citations). Georg Evers has collaborated with scholars based in Germany, Switzerland and United States. Frequent co-authors include Arik Bernard Schulze, Michael Möhr, Wolfgang E. Berdel, Christoph Schliemann, Dennis Görlich, Georg Lenz, Annalen Bleckmann, Ludger Hillejan, Irina Osiaevi and Alessandro Marra. Their work appears in journals such as Cancers, PLoS ONE, Canadian Respiratory Journal, Annals of Hematology and Therapeutic Advances in Medical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.